Clinical trial for Stroke
Official title Transcranial Magnetic Stimulation + Language Therapy to Treat Subacute Aphasia
ClinicalTrials.gov ID: NCT06968663
What this study is testing
- What it's testing
- This study is testing whether TMS combined with modified Constraint Induced Language Therapy can improve speech in people with aphasia after a stroke. It also looks at which people might benefit most.
- Who it's for
- You may be able to join if you had a stroke within the last few months and have trouble speaking.
- What's involved
- You will have a screening, a medical check, and an MRI. Then you will receive TMS and language therapy five days a week for ten sessions. Afterward you will have follow‑up visits to see how you are doing.
- Time commitment
- The study lasts about three weeks of daily sessions, plus two follow‑up visits, one right after treatment and one four months later.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Left hemisphere stroke resulting in aphasia
- The stroke must have occurred between 2 and 6 weeks prior to enrollment
- Must be able to understand the nature of the study, and give informed consent
- English proficiency
- Right-handed
You likely can't join if
- History of serious and/or ongoing issues with substance abuse
- Previous head trauma with loss of consciousness for more than 5 minutes
- History of major psychiatric illness
- Dementia, or other neurological conditions
- Epilepsy, or seizure after the stroke event
- Pacemaker
See the full eligibility criteria
- Left hemisphere stroke resulting in aphasia
- The stroke must have occurred between 2 and 6 weeks prior to enrollment
- Must be able to understand the nature of the study, and give informed consent
- English proficiency
- Right-handed
- History of serious and/or ongoing issues with substance abuse
- Previous head trauma with loss of consciousness for more than 5 minutes
- History of major psychiatric illness
- Dementia, or other neurological conditions
- Epilepsy, or seizure after the stroke event
- Pacemaker
- Diagnosis of tinnitus
- Pregnancy
The study team makes the final eligibility decision.
Where it is enrolling
- Philadelphia, Pennsylvania, United States
Compensation & support
A stipend or payment for your time may be offered.
No amount is published here because ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team, so confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.